R1 RCM has received a noncompliance notice from Nasdaq’s Listing Qualifications Department resulting from R1’s delay in filing its quarterly report on Form 10-Q for the third quarter of 2023. Nasdaq’s ...

MURRAY, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial ...

Within the last quarter, R1 RCM (NASDAQ:RCM) has observed the following analyst ratings: In the last 3 months, 5 analysts have offered 12-month price targets for R1 RCM. The company has an average ...

MURRAY, Utah, Nov. 02, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare ...

In a report released today, Daniel Grosslight from Citi downgraded R1 RCM (RCM – Research Report) to a Hold, with a price target of $14.30. Daniel Grosslight has given his Hold rating due to a ...

New Mountain Capital is offering to buy out other investors in revenue cycle management giant R1 RCM for $13.75 a share in cash. The private equity firm’s offer represents a 24% premium to R1’s ...

R1 RCM completed the restatement of previously issued financial statements after it previously identified “errors related to the accounting for certain acquiree compensation costs (e.g., transaction ...

MURRAY, Utah, Dec. 06, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) -R1 RCM said on Thursday private-equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) would ...

(Reuters) -R1 RCM said on Thursday private-equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) would acquire the healthcare technology company in a deal that values it at $8.9 ...